DrugMay 1, 2019
Morphine Sulfate Extended-Release Tablets, 60 mg, 100-count bottles recall — FDA D-1245-2019
Failed Impurities/Degradation Specifications
Class IIIFDA: TerminatedLUPIN SOMERSET
Recall history in this database
Classification mix: Class III: 7, Class II: 4.
DrugMay 1, 2019
Morphine Sulfate Extended-Release Tablets, 100 mg, 100-count bottles recall — FDA D-1246-2019
Failed Impurities/Degradation Specifications
Class IIIFDA: TerminatedLUPIN SOMERSET
DrugMay 1, 2019
Morphine Sulfate Extended-Release Tablets, 200 mg recall — FDA D-1247-2019
Failed Impurities/Degradation Specifications
Class IIIFDA: TerminatedLUPIN SOMERSET
DrugMay 1, 2019
Morphine Sulfate Extended-Release Tablets, 15 mg, 100-count bottles recall — FDA D-1243-2019
Failed Impurities/Degradation Specifications
Class IIIFDA: TerminatedLUPIN SOMERSET
DrugMay 1, 2019
Morphine Sulfate Extended-Release Tablets, 30 mg, 100-count bottles recall — FDA D-1244-2019
Failed Impurities/Degradation Specifications
Class IIIFDA: TerminatedLUPIN SOMERSET
DrugApr 17, 2019
GAVILYTE-N recall — FDA D-1113-2019
Labeling Not Elsewhere Classified; orange and cherry flavor packets incorrect list "natural lemon flavor" as an ingredient
Class IIFDA: TerminatedLUPIN SOMERSET
DrugJan 30, 2019
Fluocinolone Acetonide Topical Solution, USP, 0.01 %, 60 mL bottle recall — FDA D-0390-2019
Failed Impurities/Degradation Specifications: Expansion of October 2018 recall due to elevated out of specification results for total impurities that have been chemically identified as…
Class IIFDA: TerminatedLUPIN SOMERSET
DrugJan 9, 2019
Nitrofurantoin Oral Suspension, USP, 25mg/5mL, 230 mL bottle recall — FDA D-0346-2019
Subpotent Drug: Expansion of June 2018 recall of lots S700065 and S700619 due to below specification results for assay.
Class IIFDA: TerminatedLUPIN SOMERSET
DrugOct 31, 2018
Fluocinolone Acetonide Topical Solution, USP 0.01%, 60ml Bottle recall — FDA D-0092-2019
Failed Impurities/Degradation Specifications:Out of specification result noticed for total impurities observed during stability analysis
Class IIFDA: TerminatedLUPIN SOMERSET
DrugSep 26, 2018
Morphine Sulfate Extended-Release Tablets, 30 mg, 100-count bottle recall — FDA D-1214-2018
Failed Impurities/Degradation Specifications: Morphine Sulfate Extended Release Tablets are being recalled due to out of Specification Result noticed for Morphinone Sulfate impurity during…
Class IIIFDA: TerminatedLUPIN SOMERSET
DrugJul 11, 2018
LUPIN SOMERSET Equate ClearLAX, Polyethylene Glycol 3350 Powder for Solution, OS Osmotic recall — FDA D-0907-2018
Labeling: Not Elsewhere Classified - A private label distributor noted unfiled NDC numbers on EQ ClearLax Polyethylene Glycol 3350 NF Powder Solution of various sizes.
Class IIIFDA: TerminatedLUPIN SOMERSET
Understanding this recall history
This page summarizes recall records in which the official source identifies LUPIN SOMERSET as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.